(NASDAQ: MBOT) Microbot Medical's forecast annual revenue growth rate of 303.71% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Microbot Medical's revenue in 2026 is $346,000.On average, 5 Wall Street analysts forecast MBOT's revenue for 2026 to be $146,083,442, with the lowest MBOT revenue forecast at $65,558,219, and the highest MBOT revenue forecast at $246,830,644. On average, 5 Wall Street analysts forecast MBOT's revenue for 2027 to be $593,736,841, with the lowest MBOT revenue forecast at $362,018,277, and the highest MBOT revenue forecast at $775,753,452.
In 2028, MBOT is forecast to generate $1,651,045,138 in revenue, with the lowest revenue forecast at $1,388,833,755 and the highest revenue forecast at $1,911,174,412.